Quote | Super Quote
28651 CTCLIFE@EC2507B (CALL)
RT Nominal down0.049 -0.026 (-34.667%)

07/11/2024 14:25

{A-shares Focus}CHINA LIFE reached upper price limit

[ET Net News Agency, 7 November 2024] A-shares of CHINA LIFE (SH:601628) rose 9.7% to
RMB48.97. It hits the upper price limit of RMB49.1, and an intra-day low of RMB43.81. The
total shares traded was 27.73 million, with a value of RMB1.28b. The volume ratio is 1.6,
and the turnover rate is 0.1%.
H-shares of CHINA LIFE (02628) rose 6.2% to HK$17.42. It hits an intra-day high of
HK$17.42, and hits an intra-day low of HK$16.2. The total shares traded was 81.78 million,
with a value of HK$1.37b. The active buy/sell ratio is 62:38, with net buying turnover of
HK$335.74m. A-shares of CHINA LIFE has premium of 207.8% over H-shares.(ed)

Remark: Real time quote last updated: 22/11/2024 17:59
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.